JANE STREET GROUP, LLC - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$34,893,504
-17.7%
42,400
-28.1%
0.01%
-21.4%
Q2 2023$42,393,860
+8.6%
59,000
+24.2%
0.01%
-12.5%
Q1 2023$39,029,325
-26.0%
47,500
-35.0%
0.02%
-33.3%
Q4 2022$52,740,919
+7.2%
73,100
+2.4%
0.02%
+9.1%
Q3 2022$49,185,000
-17.1%
71,400
-28.9%
0.02%
-12.0%
Q2 2022$59,349,000100,4000.02%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q3 2023
NameSharesValueWeighting ↓
Garda Capital Partners LP 3,500$2,880,3600.13%
GROUP ONE TRADING, L.P. 31,900$26,252,4240.09%
SIMPLEX TRADING, LLC 33,500$27,5690.02%
IMC-Chicago, LLC 26,500$21,808,4400.02%
Allianz Asset Management GmbH 12,400$10,204,7040.02%
SG Americas Securities, LLC 16,700$1,1420.01%
JANE STREET GROUP, LLC 42,400$34,893,5040.01%
JPMORGAN CHASE & CO 32,900$27,075,3840.00%
Focused Wealth Management, Inc 400$12,4410.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders